Muestra la distribución de la producción WoS, Scopus y SciELO del autor.
Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.
| Firmas del autor | |
| Nombre | ALARCON-ANDRADE, GONZALO |
| Género | Hombre |
| Área Principal WOS | Medicine, General & Internal; Infectious Diseases; Pediatrics; |
| Afiliación Principal | Pontificia Universidad Católica De Chile |
| ORCID
|
0000-0001-8139-7027 |
Publicaciones en Chile
Citas Totales
Afiliaciones Chilenas
| WOS | #Pub |
|---|---|
| Medicine, General & Internal | 3 |
| Infectious Diseases | 2 |
| Pediatrics | 2 |
| Immunology | 1 |
| Scopus | #Pub |
|---|---|
| Medicine (All) | 3 |
| Infectious Diseases | 2 |
| Public Health, Environmental And Occupational Health | 1 |
| Pediatrics, Perinatology And Child Health | 1 |
| Microbiology (Medical) | 1 |
| SciELO | #Pub |
|---|---|
| Health Sciences | 1 |
| Institución | # Pub |
|---|---|
| Pontificia Universidad Católica De Chile | 6 |
| Proyecto Epistemonikos | 3 |
| Escuela De Medicina | 1 |
| Año | Firma | Institución (Incites asoc.) | H Index | Average Percentile | Impact Citation | Impact Relative World | Impact Journal Normalized Citation | Impact Category Normalized Citation | Percentage Cited | Percentage Top 1 | Percentage Top 10 | Percentage Journal Q1 | Percentage Journal Q2 | Percentage Journal Q3 | Percentage Journal Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | Alarcon, Gonzalo | Pontificia Universidad Catolica de Chile | 1.0 | 80.4 | 2.0 | 0.2 | 2.3 | 0.2 | 100.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 |
| 2024 | Alarcon-Andrade, Gonzalo | Pontificia Universidad Catolica de Chile | 2.0 | 28.5 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 66.7 | 0.0 | 0.0 | 0.0 |
| Palabra Clave | #Pub |
|---|---|
| children | 3 |
| infants | 2 |
| reacción de polimerasa en cadena | 1 |
| oral dexamethasone | 1 |
| placebo | 1 |
| placebo-controlled trial | 1 |
| polymerase chain reaction | 1 |
| post-acute covid-19 syndrome | 1 |
| prednisolone | 1 |
| prevention | 1 |
| randomized controlled-trial | 1 |
| nebulized salbutamol | 1 |
| respiratory syncytial virus | 1 |
| short-term | 1 |
| sore throat | 1 |
| steroids | 1 |
| trichomonas vaginalis | 1 |
| urealyticum | 1 |
| ureaplasma spp | 1 |
| culture | 1 |
| adn | 1 |
| adolescent | 1 |
| antibiotics | 1 |
| budesonide | 1 |
| child | 1 |
| controlled-trial | 1 |
| covid-19 | 1 |
| cultivo | 1 |
| obesity | 1 |
| dexamethasone | 1 |
| dna | 1 |
| double-blind | 1 |
| efficacy | 1 |
| intensive care units | 1 |
| mycoplasma hominis | 1 |
| adjuvant therapy | 1 |